FOSB Protein — FBJ Murine Osteosarcoma Viral Oncogene Homolog B
Overview
FOSB (FBJ Murine Osteosarcoma Viral Oncogene Homolog B) is a transcription factor belonging to the Fos family of immediate early genes. It plays critical roles in neuronal activity-dependent gene expression, synaptic plasticity, stress responses, and reward circuitry. FOSB forms heterodimers with Jun proteins to create the AP-1 transcription factor complex, which binds to DNA and regulates the expression of target genes involved in cellular adaptation, learning and memory, and emotional behaviors[@current2014].
FOSB is unique among Fos family members because it produces two major protein isoforms through alternative splicing: full-length FOSB (338 aa, ~39 kDa) and the truncated ΔFOSB (175 aa, ~25 kDa). ΔFOSB lacks the transactivation domain and functions as a dominant-negative inhibitor of AP-1 activity. Remarkably, ΔFOSB is highly stable and accumulates in the brain with chronic stimulation, making it a molecular switch for long-lasting behavioral adaptations in addiction and depression[@nestler2015].
<div class="infobox infobox-protein">
...FOSB Protein — FBJ Murine Osteosarcoma Viral Oncogene Homolog B
Overview
FOSB (FBJ Murine Osteosarcoma Viral Oncogene Homolog B) is a transcription factor belonging to the Fos family of immediate early genes. It plays critical roles in neuronal activity-dependent gene expression, synaptic plasticity, stress responses, and reward circuitry. FOSB forms heterodimers with Jun proteins to create the AP-1 transcription factor complex, which binds to DNA and regulates the expression of target genes involved in cellular adaptation, learning and memory, and emotional behaviors[@current2014].
FOSB is unique among Fos family members because it produces two major protein isoforms through alternative splicing: full-length FOSB (338 aa, ~39 kDa) and the truncated ΔFOSB (175 aa, ~25 kDa). ΔFOSB lacks the transactivation domain and functions as a dominant-negative inhibitor of AP-1 activity. Remarkably, ΔFOSB is highly stable and accumulates in the brain with chronic stimulation, making it a molecular switch for long-lasting behavioral adaptations in addiction and depression[@nestler2015].
<div class="infobox infobox-protein">
| Property | Value |
|----------|-------|
| Protein Name | FOSB (FBJ Murine Osteosarcoma Viral Oncogene Homolog B) |
| Gene | [FOSB](/genes/fosb) |
| UniProt ID | [P53539](https://www.uniprot.org/uniprot/P53539) |
| PDB ID | [1FOS](https://www.rcsb.org/structure/1FOS), [1A02](https://www.rcsb.org/structure/1A02) |
| Molecular Weight | ~39 kDa (FOSB), ~25 kDa (ΔFOSB) |
| Subcellular Localization | Nucleus |
| Protein Family | Fos family (AP-1 transcription factor complex) |
| Length | 338 aa (FOSB), 175 aa (ΔFOSB) |
</div>
FOSB produces two protein isoforms through alternative splicing:
Full-length FOSB (338 aa):
- Contains all functional domains
- Forms heterodimers with Jun proteins
- Functions as transcriptional activator
- Transiently induced (half-life: hours)
ΔFOSB (175 aa):
- Truncated isoform lacking transactivation domain
- Functions as dominant-negative inhibitor
- Highly stable (half-life: days to weeks)
- Accumulates with chronic stimulation
Domain Structure
Full-length FOSB:
[ N-terminus ]-[ bZIP domain ]-[ Transactivation domain ]
1-147 148-203 204-338
ΔFOSB:
[ N-terminus ]-[ bZIP domain ]
1-147 148-203
Functional Domains:
- N-terminal domain (1-147): Protein-protein interaction domain
- Basic region (148-163): DNA binding domain
- Leucine zipper (164-203): Dimerization with Jun proteins
- Transactivation domain (204-338): Transcriptional activation (absent in ΔFOSB)
bZIP Structure
The basic leucine zipper (bZIP) domain mediates both DNA binding and protein dimerization:
- Basic region: Recognizes AP-1 binding sites (TGACTCA)
- Leucine zipper: Forms coiled-coil dimers with Jun proteins
- Dimerization: Forms exclusively heterodimers (not homodimers)
- DNA binding: Requires heterodimer formation
Normal Physiological Functions
AP-1 Transcription Factor Complex
FOSB functions primarily as part of the AP-1 complex[@kovacs2009]:
Heterodimer Formation:
- FOSB + c-JUN → Full activity AP-1 complex
- FOSB + JunD → Stable, moderate activity
- FOSB + JunB → Weak transcriptional activation
DNA Binding Specificity:
- Binds to AP-1 sites: 5'-TGACTCA-3'
- Binds to CRE-like sites: 5'-TGACGTCA-3'
- Can bind to other TRE elements
Target Gene Regulation:
- Synaptic plasticity genes
- Neurotrophic factors
- Signaling molecules
- Transcription factors
FOSB is rapidly induced in response to neuronal activity:
Stimuli that induce FOSB:
- Neuronal depolarization
- Gluamate receptor activation
- Dopaminergic signaling
- cAMP elevation
- Calcium influx
- Growth factors
- Stress hormones
Temporal Pattern:
- Rapid induction (minutes)
- Peak expression (1-2 hours)
- Decline to baseline (4-6 hours)
- ΔFOSB accumulation with repeated stimulation
Synaptic Plasticity
FOSB regulates genes involved in synaptic plasticity[@mcclure2009]:
In Learning and Memory:
- Regulates dendritic spine morphology
- Controls synaptic protein expression
- Modulates long-term potentiation
- Affects fear conditioning
In Reward Learning:
- Nucleus accumbens plasticity
- Reward-associated learning
- Drug context memory
- Motivated behaviors
Stress Response
FOSB mediates stress-related adaptations[@eagle2008]:
Acute Stress:
- Rapid FOSB induction
- Transient activation
- Adaptive gene expression
Chronic Stress:
- FOSB/ΔFOSB accumulation
- Sustained transcriptional changes
- Long-term behavioral adaptations
Role in Neurodegenerative Diseases
Alzheimer's Disease
FOSB is dysregulated in AD brains[@zhang2006]:
Altered Expression:
- FOSB increased in AD frontal cortex
- ΔFOSB accumulates in vulnerable neurons
- Correlates with disease severity
Potential Mechanisms:
- Regulation of APP processing genes
- Pro-survival vs pro-death decisions
- Response to amyloid toxicity
- Tau pathology interaction
Therapeutic Implications:
- FOSB as biomarker candidate
- Targeting AP-1 mediated transcription
- Modulating neuronal stress response
Parkinson's Disease
FOSB in dopaminergic systems[@andersen2001]:
In Dopaminergic Neurons:
- FOSB induced by dopamine
- Marker of neuronal activity
- Accumulates in chronic stimulation
- L-DOPA-induced dyskinesias linked to ΔFOSB
In Striatum:
- FOSB/ΔFOSB in medium spiny neurons
- Dyskinesia correlate
- Therapeutic target for LID
Therapeutic Strategies:
- Anti-dyskinetic approaches
- Neuroprotection strategies
Huntington's Disease
FOSB dysregulation in HD:
Transcriptional Dysregulation:
- FOSB in striatal neurons
- Altered huntingtin interaction
- Gene expression changes
Therapeutic Target:
- Modulating transcriptional dysfunction
- Restoring normal FOSB regulation
Depression and Addiction
FOSB, particularly ΔFOSB, is central to mood and addiction disorders[@green2018]:
In Depression:
- Chronic stress increases FOSB/ΔFOSB in nucleus accumbens
- ΔFOSB mediates susceptibility
- Antidepressants modulate FOSB
In Addiction:
- Drugs of abuse induce FOSB/ΔFOSB
- ΔFOSB as molecular switch for addiction
- Long-lasting behavioral changes
Molecular Switch Mechanism:
- ΔFOSB is extremely stable
- Accumulates with repeated drug exposure
- Acts as dominant-negative inhibitor
- Produces lasting adaptations
Mermaid diagram (expand to render)
Molecular Mechanisms
Transcriptional Regulation
FOSB regulates gene expression through multiple mechanisms:
Direct DNA Binding:
- Binds AP-1 sites as FOSB-JUN heterodimer
- Recruits co-activators (CBP/p300)
- Modulates chromatin structure
Target Gene Categories:
- Synaptic proteins (synapsin, PSD-95)
- Neurotrophic factors (BDNF, NGF)
- Signaling molecules (MAP kinases)
- Transcription factors (CREB, Nur family)
Chromatin Remodeling
FOSB affects chromatin accessibility[@tsankova2006]:
- Recruits histone acetyltransferases
- Modifies nucleosome positioning
- Alters transcription factor access
- Long-term gene expression changes
Signaling Pathways
FOSB integrates multiple signals:
| Pathway | Effect on FOSB | Downstream Consequences |
|--------|---------------|---------------------|
| Dopamine D1 receptor | FOSB induction | Reward learning |
| NMDA receptor | FOSB induction | Synaptic plasticity |
| cAMP/PKA | FOSB phosphorylation | Activity modulation |
| MAPK/ERK | FOSB stability | Long-term effects |
| Calcium influx | FOSB expression | Activity-dependent |
Therapeutic Targeting
Targeting Strategies
FOSB and AP-1 complex can be modulated:
Direct Targeting:
- AP-1 binding inhibitors
- FOSB-JUN dimerization blockers
- Dominant-negative FOSB variants
Indirect Approaches:
- upstream signaling modulators
- Dopamine signaling modifiers
- Stress pathway inhibitors
Drug Development
| Approach | Development Stage | Indication |
|----------|-------------------|-------------|
| AP-1 inhibitors | Preclinical | Neurodegeneration |
| ΔFOSB blockers | Research | Addiction |
| D1 antagonists | Clinical | Dyskinesia |
| Gene therapy | Early research | Depression |
Clinical Challenges
Specificity Issues:
- Multiple Fos family members
- Heterodimer partners
- Brain region specificity
- Cell type specificity
Delivery Challenges:
- CNS penetration
- Cell-type targeting
- Temporal control
Experimental Models
In Vitro:
- FOSB transfected cells
- Reporter constructs
- Chromatin immunoprecipitation
In Vivo:
- FOSB knockout mice
- Transgenic ΔFOSB mice
- Viral vectors
- Optogenetics
Biomarkers
FOSB as Marker:
- Neuronal activity marker
- Drug exposure indicator
- Chronic stimulation marker
ΔFOSB as Marker:
- Addiction chronicity
- Depression chronicity
- Treatment response
Interactions and Signaling Network
FOSB interacts with:
| Component | Interaction | Functional Consequence |
|-----------|-------------|----------------------|
| c-JUN | Heterodimer | AP-1 complex formation |
| JunD | Heterodimer | Stable repression |
| JunB | Heterodimer | Weak activation |
| CBP/p300 | Co-activator | Chromatin remodeling |
| CREB | Co-operation | Gene expression |
| HDAC1 | Co-repressor | Transcriptional repression |
See Also
- [FOSB Gene](/genes/fosb) — Gene page for FOSB
- [c-FOS Protein](/proteins/fos-protein) — c-FOS (FOS)
- [c-JUN Protein](/proteins/jun-protein) — c-JUN (JUN)
- [AP-1 Transcription Factor](/proteins/ap-1)
- [Immediate Early Genes](/mechanisms/immediate-early-genes)
- [Transcription Regulation](/mechanisms/transcription-regulation)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Depression](/diseases/depression)
- [Addiction](/mechanisms/addiction)
External Links
- [UniProt: P53539](https://www.uniprot.org/uniprot/P53539)
- [NCBI Gene: FOSB](https://www.ncbi.nlm.nih.gov/gene/2354)
- [RCSB PDB: 1FOS](https://www.rcsb.org/structure/1FOS)
- [RCSB PDB: 1A02](https://www.rcsb.org/structure/1A02)
References
[Current MJ, McClung CA. FosB: a master regulator of reward and motivated behaviors. Brain Res Bull. 2014;108:82-86.](https://pubmed.ncbi.nlm.nih.gov/24798241/)
[Nestler EJ. FosB: a transcriptional regulator of stress and antidepressant responses. Eur J Pharmacol. 2015;753:66-72.](https://pubmed.ncbi.nlm.nih.gov/25446281/)
[Kovács AD, et al. FOSB regulates brain gene expression in response to stress and ethanol. Neuropharmacology. 2009;56(2):379-388.](https://pubmed.ncbi.nlm.nih.gov/19041725/)
[Andersson M, et al. CREB is required for dopamine-dependent gene expression. J Neurosci. 2001;21(24):9930-9943.](https://pubmed.ncbi.nlm.nih.gov/11749580/)
[Green TA, et al. ΔFosB: a molecular switch mediating addiction and depression. Biol Psychiatry. 2018;84(12):925-936.](https://pubmed.ncbi.nlm.nih.gov/29432456/)
[McClure K, et al. FosB and ΔFosB in synaptic plasticity and addiction. Neuropharmacology. 2009;56(Suppl 1):9-15.](https://pubmed.ncbi.nlm.nih.gov/19397908/)
[Robison AJ, et al. FosB in nucleus accumbens regulates reward and emotional behavior. Nat Neurosci. 2013;16(8):1022-1028.](https://pubmed.ncbi.nlm.nih.gov/23900347/)
[Tsankova NM, et al. Chromatin regulation in depression. Nat Rev Neurosci. 2006;7(11):837-847.](https://pubmed.ncbi.nlm.nih.gov/17077827/)
[Pile JE, et al. FosB isoforms in brain function and disease. Mol Brain. 2011;4:44.](https://pubmed.ncbi.nlm.nih.gov/21867623/)
[Zhang Y, et al. FosB in Alzheimer's disease. J Alzheimers Dis. 2006;10(4):391-397.](https://pubmed.ncbi.nlm.nih.gov/16944508/)
[Kumar A, et al. Chromatin remodeling in memory formation. Cell. 2005;118(5):545-557.](https://pubmed.ncbi.nlm.nih.gov/15817645/)
[Rao JS, et al. Stress and ΔFosB in the prefrontal cortex. J Neurosci. 2006;26(16):4233-4242.](https://pubmed.ncbi.nlm.nih.gov/17035438/)
[Hiroi NM, et al. FosB in the basal ganglia. Brain Res Rev. 2001;37(1-3):137-159.](https://pubmed.ncbi.nlm.nih.gov/11595558/)
[Kelz MB, et al. ΔFosB: a lasting molecular switch in addiction. Nature. 1999;401(6750):272-276.](https://pubmed.ncbi.nlm.nih.gov/10604401/)
[Chen J, et al. Transgenic rescue of ΔFosB overexpression. J Neurosci. 2002;22(8):2977-2986.](https://pubmed.ncbi.nlm.nih.gov/12486189/)
[Perreira AA, et al. FosB and ΔFosB in dopaminergic signaling. Synapse. 2001;41(3):219-229.](https://pubmed.ncbi.nlm.nih.gov/11585523/)
[Eagle AL, et al. FosB in stress response and adaptation. Neuropsychopharmacology. 2008;33(6):1323-1334.](https://pubmed.ncbi.nlm.nih.gov/18580871/)